Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction
1 other identifier
interventional
230
1 country
1
Brief Summary
Acidification of vaginal pH has been proposed as a potential factor that could help increase the efficacy of vaginal prostaglandins in labor induction. The aim of the present randomized controlled trial is to evaluate the impact of an acidic vaginal pH on the progress of labor induction with dinoprostone (Prostaglandin E2 - PGE2) vaginal tablet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2021
CompletedFirst Posted
Study publicly available on registry
October 29, 2021
CompletedStudy Start
First participant enrolled
October 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFebruary 20, 2024
February 1, 2024
1.2 years
October 18, 2021
February 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Interval from induction to delivery
Time interval (minutes)
36 hours
Secondary Outcomes (3)
Interval from induction to active labor
36 hours
Interval from induction to second stage of labor
36 hours
Failure of induction of labor
36 hours
Study Arms (2)
Vaginal washing 5% acetic acid
EXPERIMENTALVaginal washing 0.9% N/S
PLACEBO COMPARATORInterventions
Induction of labor (vaginal tablet dinoprostone and vaginal washing with 5% acetic acid)
Induction of labor (vaginal tablet dinoprostone and vaginal washing 0.9% NS)
Eligibility Criteria
You may qualify if:
- Singleton pregnancy
- Full term (\>37 weeks)
- Cephalic presentation
- Reactive NST (nonstress test)
- Absence of spontaneous uterine contractions
- No contraindications to vaginal delivery
You may not qualify if:
- Multifetal pregnancy
- Fetal malpresentation
- Preterm delivery (\<37 weeks)
- Advanced maternal age (\>40 years)
- Bishop score \> 7
- Fetal macrosomia ( \>4500 gr)
- Non reassuring NST (nonstress test)
- Suspected chorioamnionitis
- Previous cesarean delivery or other uterine surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandra General Hospital
Athens, 11528, Greece
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Georgios Daskalakis
Alexandra General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Randomization will be computer generated. Allocation concealment will be ensured by opaque sealed envelopes. Blinding of outcomes assessor, principal as well as other investigators will be ensured as randomization will be performed by an external investigator that will not participate in the clinical process of the study or the statistical analysis. The ward midwife will open the randomization envelope after patient enrollment and different types of vaginal washing will be applied as per randomization. Participant as well outcomes assessor (physician that will evaluate the progress of labor as well statistician involved in the analysis) will be blinded to the procedure.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Obstetrics and Gynecology
Study Record Dates
First Submitted
October 18, 2021
First Posted
October 29, 2021
Study Start
October 29, 2021
Primary Completion
December 29, 2022
Study Completion
December 30, 2022
Last Updated
February 20, 2024
Record last verified: 2024-02